NEULAND LABORATORIES
Back to Balance Sheet
|
NEULAND LABORATORIES Last 5 Year Long Term Provisions History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Long Term Provisions | ₹7.22 Cr | ₹7.61 Cr | ₹10 Cr | ₹12 Cr | ₹9.44 Cr |
What is the latest Long Term Provisions ratio of NEULAND LABORATORIES ?
| Year | Long Term Provisions |
|---|---|
| Mar2025 | ₹7.22 Cr |
| Mar2024 | ₹7.61 Cr |
| Mar2023 | ₹10 Cr |
| Mar2022 | ₹12 Cr |
| Mar2021 | ₹9.44 Cr |
How is Long Term Provisions of NEULAND LABORATORIES Trending?
| Years | Long Term Provisions | % Change | |
|---|---|---|---|
| Mar2025 | ₹7.22 Cr | -5.10 | |
| Mar2024 | ₹7.61 Cr | -26.05 | |
| Mar2023 | ₹10 Cr | -13.62 | |
| Mar2022 | ₹12 Cr | 26.22 | |
| Mar2021 | ₹9.44 Cr | - | |
Compare Long Term Provisions of peers of NEULAND LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NEULAND LABORATORIES | ₹19,134.7 Cr | 13% | 18.5% | 22.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹397,018.0 Cr | -2.3% | -8.5% | -3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹162,454.0 Cr | 5.3% | -3.4% | 3.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹140,702.0 Cr | 3.7% | -4.9% | 26% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,830.0 Cr | 1.2% | -4.2% | 5.3% | Stock Analytics | |
| CIPLA | ₹99,325.0 Cr | 2.4% | -7.2% | -18.1% | Stock Analytics | |
NEULAND LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NEULAND LABORATORIES | 13% |
18.5% |
22.4% |
| SENSEX | 5.8% |
-1.7% |
1.2% |
You may also like the below Video Courses